WENDY KING: Open Payments
NPI 1235210451 · LARAMIE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 60 payments from 17 companies in 2025. Trend: 2023 $793 · 2024 $835 · 2025 $1,086
Food & beverage: $1,081Education: $5
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $170 |
| Otsuka America Pharmaceutical, Inc. | 10 | $164 |
| Lundbeck LLC | 13 | $160 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Novo Nordisk Inc | 4 | $72 |
| Neurocrine BioSciences, Inc. | 2 | $72 |
| Exact Sciences Corporation | 3 | $58 |
| Alkermes, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
Products named: REXULTI, COBENFY, INGREZZA, Cologuard Collection Kit, BREZTRI, ARISTADA, CAPLYTA, Wegovy.
Industry payments across WY — which companies pay providers there.
